Logo image of CG

CARLYLE GROUP INC/THE (CG) Stock Fundamental Analysis

NASDAQ:CG - Nasdaq - US14316J1088 - Common Stock - Currency: USD

49.86  -2.15 (-4.13%)

After market: 49.85 -0.01 (-0.02%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CG. CG was compared to 225 industry peers in the Capital Markets industry. Both the profitability and financial health of CG have multiple concerns. CG is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CG had positive earnings in the past year.
In the past year CG has reported a negative cash flow from operations.
CG had positive earnings in 4 of the past 5 years.
In multiple years CG reported negative operating cash flow during the last 5 years.
CG Yearly Net Income VS EBIT VS OCF VS FCFCG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B

1.2 Ratios

CG's Return On Assets of -0.12% is on the low side compared to the rest of the industry. CG is outperformed by 76.71% of its industry peers.
CG's Return On Equity of -0.50% is on the low side compared to the rest of the industry. CG is outperformed by 75.34% of its industry peers.
CG has a Return On Invested Capital of 0.70%. This is in the lower half of the industry: CG underperforms 73.06% of its industry peers.
Industry RankSector Rank
ROA -0.12%
ROE -0.5%
ROIC 0.7%
ROA(3y)2.42%
ROA(5y)4.7%
ROE(3y)8.02%
ROE(5y)18.67%
ROIC(3y)N/A
ROIC(5y)N/A
CG Yearly ROA, ROE, ROICCG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

CG's Profit Margin has improved in the last couple of years.
The Operating Margin of CG (2.77%) is worse than 75.34% of its industry peers.
In the last couple of years the Operating Margin of CG has declined.
With a Gross Margin value of 43.87%, CG perfoms like the industry average, outperforming 40.64% of the companies in the same industry.
In the last couple of years the Gross Margin of CG has declined.
Industry RankSector Rank
OM 2.77%
PM (TTM) N/A
GM 43.87%
OM growth 3Y-18.12%
OM growth 5Y-7.49%
PM growth 3Y-17.81%
PM growth 5Y12.96%
GM growth 3Y-0.37%
GM growth 5Y-5.06%
CG Yearly Profit, Operating, Gross MarginsCG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

CG has less shares outstanding than it did 1 year ago.
CG has more shares outstanding than it did 5 years ago.
CG has a better debt/assets ratio than last year.
CG Yearly Shares OutstandingCG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CG Yearly Total Debt VS Total AssetsCG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 0.83, we must say that CG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.83, CG perfoms like the industry average, outperforming 46.58% of the companies in the same industry.
A Debt/Equity ratio of 1.57 is on the high side and indicates that CG has dependencies on debt financing.
CG has a Debt to Equity ratio of 1.57. This is in the lower half of the industry: CG underperforms 72.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.57
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACCN/A
WACCN/A
CG Yearly LT Debt VS Equity VS FCFCG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

CG has a Current Ratio of 0.43. This is a bad value and indicates that CG is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.43, CG is not doing good in the industry: 78.54% of the companies in the same industry are doing better.
A Quick Ratio of 0.43 indicates that CG may have some problems paying its short term obligations.
The Quick ratio of CG (0.43) is worse than 74.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.43
CG Yearly Current Assets VS Current LiabilitesCG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.96% over the past year.
The Earnings Per Share has been growing by 16.58% on average over the past years. This is quite good.
The Revenue has grown by 92.50% in the past year. This is a very strong growth!
Measured over the past years, CG shows a quite strong growth in Revenue. The Revenue has been growing by 9.95% on average per year.
EPS 1Y (TTM)12.96%
EPS 3Y-9.94%
EPS 5Y16.58%
EPS Q2Q%6.98%
Revenue 1Y (TTM)92.5%
Revenue growth 3Y-14.83%
Revenue growth 5Y9.95%
Sales Q2Q%5.81%

3.2 Future

CG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.56% yearly.
CG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.60% yearly.
EPS Next Y18.73%
EPS Next 2Y15.44%
EPS Next 3Y13.35%
EPS Next 5Y9.56%
Revenue Next Year20.61%
Revenue Next 2Y15.66%
Revenue Next 3Y13.6%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CG Yearly Revenue VS EstimatesCG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CG Yearly EPS VS EstimatesCG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

CG is valuated correctly with a Price/Earnings ratio of 13.62.
CG's Price/Earnings ratio is in line with the industry average.
CG is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 11.47, the valuation of CG can be described as reasonable.
Based on the Price/Forward Earnings ratio, CG is valued a bit cheaper than 61.19% of the companies in the same industry.
CG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.62
Fwd PE 11.47
CG Price Earnings VS Forward Price EarningsCG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

60.27% of the companies in the same industry are more expensive than CG, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 78.71
CG Per share dataCG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CG's earnings are expected to grow with 13.35% in the coming years.
PEG (NY)0.73
PEG (5Y)0.82
EPS Next 2Y15.44%
EPS Next 3Y13.35%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.69%, CG has a reasonable but not impressive dividend return.
CG's Dividend Yield is comparable with the industry average which is at 9.98.
CG's Dividend Yield is comparable with the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

The dividend of CG decreases each year by -1.38%.
CG has paid a dividend for at least 10 years, which is a reliable track record.
CG has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-1.38%
Div Incr Years3
Div Non Decr Years4
CG Yearly Dividends per shareCG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

CG has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1813.31%
EPS Next 2Y15.44%
EPS Next 3Y13.35%
CG Yearly Income VS Free CF VS DividendCG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

More info and screens

CARLYLE GROUP INC/THE

NASDAQ:CG (2/21/2025, 8:07:54 PM)

After market: 49.85 -0.01 (-0.02%)

49.86

-2.15 (-4.13%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-11 2025-02-11/bmo
Earnings (Next)04-29 2025-04-29/bmo
Inst Owners61.35%
Inst Owner Change5.21%
Ins Owners26.62%
Ins Owner Change-1.81%
Market Cap17.83B
Analysts73.08
Price Target58.51 (17.35%)
Short Float %3.41%
Short Ratio4.2
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend1.38
Dividend Growth(5Y)-1.38%
DP-1813.31%
Div Incr Years3
Div Non Decr Years4
Ex-Date02-21 2025-02-21 (0.35)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.59%
Min EPS beat(2)-8.37%
Max EPS beat(2)1.19%
EPS beat(4)3
Avg EPS beat(4)1.07%
Min EPS beat(4)-8.37%
Max EPS beat(4)7.48%
EPS beat(8)6
Avg EPS beat(8)5.01%
EPS beat(12)9
Avg EPS beat(12)9%
EPS beat(16)13
Avg EPS beat(16)15.34%
Revenue beat(2)0
Avg Revenue beat(2)-5.89%
Min Revenue beat(2)-7.44%
Max Revenue beat(2)-4.35%
Revenue beat(4)1
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-7.44%
Max Revenue beat(4)2.34%
Revenue beat(8)2
Avg Revenue beat(8)-4.85%
Revenue beat(12)4
Avg Revenue beat(12)5.08%
Revenue beat(16)8
Avg Revenue beat(16)54.19%
PT rev (1m)1.63%
PT rev (3m)12.13%
EPS NQ rev (1m)-7.62%
EPS NQ rev (3m)-7.21%
EPS NY rev (1m)-3.42%
EPS NY rev (3m)-3.23%
Revenue NQ rev (1m)-6.65%
Revenue NQ rev (3m)-5.73%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 13.62
Fwd PE 11.47
P/S 3.45
P/FCF N/A
P/OCF N/A
P/B 3.22
P/tB 3.66
EV/EBITDA 78.71
EPS(TTM)3.66
EY7.34%
EPS(NY)4.35
Fwd EY8.72%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS14.47
BVpS15.51
TBVpS13.63
PEG (NY)0.73
PEG (5Y)0.82
Profitability
Industry RankSector Rank
ROA -0.12%
ROE -0.5%
ROCE 0.89%
ROIC 0.7%
ROICexc 0.79%
ROICexgc 1.77%
OM 2.77%
PM (TTM) N/A
GM 43.87%
FCFM N/A
ROA(3y)2.42%
ROA(5y)4.7%
ROE(3y)8.02%
ROE(5y)18.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-53.5%
ROICexcg growth 5Y-16.42%
ROICexc growth 3Y-33.92%
ROICexc growth 5Y-7.26%
OM growth 3Y-18.12%
OM growth 5Y-7.49%
PM growth 3Y-17.81%
PM growth 5Y12.96%
GM growth 3Y-0.37%
GM growth 5Y-5.06%
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 1.57
Debt/FCF N/A
Debt/EBITDA 26.93
Cap/Depr 37.65%
Cap/Sales 1.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.43
Altman-Z 0.83
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.96%
EPS 3Y-9.94%
EPS 5Y16.58%
EPS Q2Q%6.98%
EPS Next Y18.73%
EPS Next 2Y15.44%
EPS Next 3Y13.35%
EPS Next 5Y9.56%
Revenue 1Y (TTM)92.5%
Revenue growth 3Y-14.83%
Revenue growth 5Y9.95%
Sales Q2Q%5.81%
Revenue Next Year20.61%
Revenue Next 2Y15.66%
Revenue Next 3Y13.6%
Revenue Next 5YN/A
EBIT growth 1Y-65.18%
EBIT growth 3Y-30.27%
EBIT growth 5Y1.71%
EBIT Next Year18.78%
EBIT Next 3Y17.83%
EBIT Next 5Y10.09%
FCF growth 1Y6.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.24%
OCF growth 3YN/A
OCF growth 5YN/A